News
18h
Zacks Investment Research on MSNHologic's Panther Fusion Signals More Molecular Diagnostics Upside
Hologic’s HOLX fully automated, high-throughput Panther platform remains the foundation of its molecular diagnostics business. The Panther Fusion module, a 2016 addition to the base system, provides ...
A recent market analysis has highlighted significant growth potential within Hologic's molecular diagnostics business, with the Panther Fusion system identified as a primary catalyst. The platform's ...
The 1,000 th Panther was unveiled today at PathGroup, one of the largest private providers of comprehensive anatomic, clinical and molecular pathology laboratory services in the country. Founded ...
MARLBOROUGH, Mass., June 18, 2018 /CNW/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that it has obtained approval from Health Canada for its new Panther Fusion® system and Panther Fusion ...
Hologic, Inc. HOLX announced the expansion of the Panther Scalable Solutions (PSS) portfolio with product launches. The products are now commercially available in the United States and Europe. While ...
Hologic's (HOLX) receipt of Health Canada approval for the new Panther Fusion system and Panther Fusion assays, for respiratory virus infections, is expected to boost the top line in the near term.
The addition of Hologic's Aptima HPV assay to the fully automated Panther system expands the ability of laboratories to run multiple tests from a single specimen.
This press release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic’s Aptima® SARS-CoV-2/Flu assay and Panther system.
Marlborough medical device manufacturer Hologic has placed its 1,000th Panther Molecular Diagnostics System in the United States.
Hospital, public health and reference laboratories can perform the test on Hologic’s Panther Fusion system, a fully automated, high-throughput molecular diagnostic platform that is widely used ...
MARLBOROUGH, Mass., June 29, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) has obtained a CE mark in Europe for its new Panther Fusion system and Panther Fusion assays for flu and respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results